Sales Highlights (unaudited):

Global	H1 sales AUD$4.2 million up 5% on prior comparative period (pcp) Q2 sales AUD$2.2 million up 11% on prior quarter
Australia	H1 sales AUD$3.3 million up 13% on prior comparative period (pcp) Q2 sales AUD$1.7 million up 11% on prior quarter Australian launch of ProIBS®
Canada	H1 sales AUD$56 thousand down 85% on prior comparative period (pcp) Q2 sales AUD$42 thousand up 191% on prior quarter
USA	H1 sales AUD$0.9 million up 17% on prior comparative period (pcp) Q2 sales AUD$0.4 million up 8% on prior quarter

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.